SL-89.0591
Изглед
Nazivi | |
---|---|
Preferisani IUPAC naziv
2-[3-[4-(5-hloro-2-metoksifenil)piperazin-1-il]propilamino]pyrimidin-4-karboksamid | |
Drugi nazivi
CHEMBL24981
SL 89.0591 SCHEMBL5597266 BDBM50160159 L013345 | |
Identifikacija | |
3D model (Jmol)
|
|
| |
Svojstva | |
C19H25ClN6O2 | |
Molarna masa | 404,90 g·mol−1 |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
Reference infokutije | |
SL-89.0591 je antagonist alfa adrenergičkog receptora.[3]
Reference
[уреди | уреди извор]- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Barry Kenny; Alan Collis; Alasdair Naylor; Michael Wyllie (2008). „Section Review Central & Peripheral Nervous Systems: α1-Adrenoceptor antagonists as treatments for benign prostatic hyperplasia”. Expert Opinion on Investigational Drugs. 4 (10): 915—923. doi:10.1517/13543784.4.10.915.